IRIS
MARONGIU, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.111
AS - Asia 1.422
SA - Sud America 974
EU - Europa 800
AF - Africa 54
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.367
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.029
BR - Brasile 832
SG - Singapore 651
IT - Italia 358
CN - Cina 252
HK - Hong Kong 224
DE - Germania 139
VN - Vietnam 91
AR - Argentina 56
FI - Finlandia 56
GB - Regno Unito 53
CA - Canada 30
UA - Ucraina 30
FR - Francia 29
MX - Messico 29
IN - India 27
TR - Turchia 27
RU - Federazione Russa 25
BD - Bangladesh 22
VE - Venezuela 20
IQ - Iraq 19
ZA - Sudafrica 19
NL - Olanda 18
PL - Polonia 18
EC - Ecuador 17
KR - Corea 17
CO - Colombia 16
SE - Svezia 14
AT - Austria 12
CZ - Repubblica Ceca 11
JP - Giappone 11
ES - Italia 10
AZ - Azerbaigian 9
BE - Belgio 9
PK - Pakistan 9
UZ - Uzbekistan 9
CL - Cile 7
IL - Israele 7
KE - Kenya 7
LT - Lituania 7
UY - Uruguay 7
BO - Bolivia 6
ID - Indonesia 6
JM - Giamaica 6
PY - Paraguay 6
PE - Perù 5
AU - Australia 4
KG - Kirghizistan 4
KZ - Kazakistan 4
MA - Marocco 4
SA - Arabia Saudita 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
EG - Egitto 3
GH - Ghana 3
NP - Nepal 3
OM - Oman 3
PH - Filippine 3
SN - Senegal 3
AL - Albania 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
HN - Honduras 2
IR - Iran 2
LB - Libano 2
MY - Malesia 2
QA - Qatar 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CD - Congo 1
CH - Svizzera 1
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
HR - Croazia 1
JO - Giordania 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
NE - Niger 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TM - Turkmenistan 1
UG - Uganda 1
Totale 5.367
Salva come PNG Salva come JPEG
Città #
Dallas 1.199
Singapore 356
Hong Kong 220
Ashburn 116
Beijing 108
Chandler 78
Munich 71
São Paulo 55
Los Angeles 44
New York 41
Shanghai 39
Ho Chi Minh City 36
Belo Horizonte 32
Boardman 32
Cagliari 29
Rio de Janeiro 28
Turku 26
Helsinki 23
Milan 22
Sassari 19
Florence 18
West Jordan 18
Rome 17
Seoul 17
Brasília 16
Buenos Aires 16
Warsaw 16
Hanoi 15
Frankfurt am Main 14
Princeton 14
Johannesburg 13
Montreal 13
Recife 13
Santa Clara 13
Alghero 12
Chicago 12
Jacksonville 12
Nuremberg 12
Poplar 12
Atlanta 11
Boston 11
Brooklyn 11
Denver 11
Falkenstein 11
Manaus 11
Stockholm 11
Campinas 10
Düsseldorf 10
Guarulhos 10
London 10
Orem 10
Salvador 10
Tokyo 10
Ankara 9
Baku 9
Curitiba 9
Goiânia 9
Seattle 9
Tashkent 9
Brussels 8
Chennai 8
Lauterbourg 8
Manchester 8
Mexico City 8
Nova Iguaçu 8
Ribeirão Preto 8
Romola 8
Baghdad 7
Bologna 7
Brno 7
Guayaquil 7
Lappeenranta 7
Wilmington 7
Amsterdam 6
Ann Arbor 6
Anápolis 6
Columbus 6
Dearborn 6
Dhaka 6
Fortaleza 6
Istanbul 6
Nairobi 6
Nanjing 6
Osasco 6
Pelotas 6
Santiago 6
Selargius 6
Shenzhen 6
The Dalles 6
Toronto 6
Trieste 6
Campo Grande 5
Caxias do Sul 5
Conselheiro Lafaiete 5
Cuiabá 5
Hangzhou 5
Hortolândia 5
João Pessoa 5
Juiz de Fora 5
Kingston 5
Totale 3.307
Salva come PNG Salva come JPEG
Nome #
The role of 123I-MIBG cardiac scintigraphy in the patients with movement disorders (MD). 320
The impact of risk factors ascertained at the surgery of the primary tumor on metastasis appearance and outcome of patients with papillary thyroid microcarcinoma (PTMC). 296
123I-Ioflupane brain SPECT (I-SPECT) and brain parenchyma sonography (BPS) combined use in movement disorder diagnosis 159
131I-SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinomas (DTC) in long-term follow-up 158
Cortical metabolic 18F-FDG PET assessment and striatal dopamine transporter SPECT imaging in suspected early neurodegenerative disorders with uncertain movement and cognitive symptoms 137
Brain 18F-FDG PET/CT usefulness in primary progressive aphasia variant diagnosis and in their development into Alzheimer’s disease or fronto-temporal dementia 134
18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage. 133
Neck lymph node metastases in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a diagnostic 131I-SPECT/CT study 129
Qualitative (Q) and semiquantitative (SQ) brain 18FFDG PET analyses in primary progressive aphasia (PPA) variants 126
The diagnostic usefulness of131i-spect/ct at both radioiodine ablation and during long-term follow-up in patients thyroidectomized for differentiated thyroid carcinoma: Analysis of tissue risk factors ascertained at surgery and correlated with metastasis appearance 121
18F-FDG Brain PET/CT Metabolic Imaging in Patients with Suspected Autoimmune Encephalitis (AE) in the Early Stage: Can the Procedure Play a Complementary Diagnostic Role? 120
Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a 131I-SPECT/CT study. 119
131I-SPECT/CT usefulness in patients with Hashimoto’s thyroiditis (HT) coexistence with papillary thyroid carcinoma (PC) without risk factors at surgery followed in a long-term follow-up after thyroidectomy and radioiodine ablation 115
18F-FDG brain and whole body (WB) PET/CT in intracranial leptomeningeal carcinomatosis and in paraneoplastic neurologic syndromes 115
Axillary lymph node hypermetabolism (ALNH) related to COVID-19 vaccination in cancer patients undergoing 18F-FDG PET/CT: a single centre study on 500 cases 108
A multicenter 18F-FDG-PET/CT study in solitary pulmonary nodule: Qualitative and Semiquantitative parameters to predict the risk of malignancy 108
The prognostic role of baseline and post neoadjuvant chemotherapy [18F]FDG PET/CT in triple-negative breast cancer: preliminary results of TRINE-PET trial 105
A Comparative Follow-Up Study of Patients with Papillary Thyroid Carcinoma Associated or Not with Graves' Disease 102
Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma: A Follow-Up Study in Patients with Absence of Aggressive Risk Factors at the Surgery of the Primary Tumor 98
Brain 123I-ioflupane SPECT and 18F-FDG PET combined use in movement and cognitive associated diseases of recent appearance 97
Qualitative and semiquantitative parameters in solitary pulmonary nodule: a multicenter 18F-FDG-PET/CT study 94
Differential Diagnosis of Alzheimer Disease vs. Mild Cognitive Impairment Based on Left Temporal Lateral Lobe Hypomethabolism on 18F-FDG PET/CT and Automated Classifiers 92
Large Italian Multicenter Study on Prognostic Value of Baselines Variables in mCRPC Patients Treated with 223RaCl2: Ten Years of Clinical Experience 92
131I-SPECT/CT after radioiodine therapy in patients with differentiated thyroid carcinoma 92
131I-SPECT/CT at the first radioiodine ablation and during follow-up in patients with differentiated thyroid carcinoma (DTC). 91
Breast-Specific Gamma Imaging: An Added Value in the Diagnosis of Breast Cancer, a Systematic Review 90
A multicenter study for the analysis of early onset Parkinson’s disease population: the role of 123I-FP-CIT and 123I-MIBG 89
Performance Analysis of Six Semi-Automated Tumour Delineation Methods on [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in Patients with Head and Neck Cancer 88
Pet-radiomics in lymphoma and multiple myeloma: update of current literature 88
123I-MIBG Cardiac Scintigraphy and Heart/Mediastinum Ratio in Neurodegenerative Disorders: Is Delayed Scan Really Necessary? 87
Brain SPECT DAT imaging and 18F-FDG PET/CT combined use in the early stage of movement and cognitive associated neurodegenerative disorders 86
Harmonization of multi-center data for preliminary investigation of cardiac MIBG scintigraphy in Parkinsonism (ITA-MIBG STUDY): a novel approach using phantom calibration with tube and bottle. 85
Radiomics analysis on PET/CT scans to discriminate malignant (adenocarcinoma) and benign pulmonary nodules 84
Prognostic role of the risk factors in the follow-up of T1B-T2 papillary thyroid carcinoma (PC) 82
Prostate-Specific Membrane Antigen Radioligand Therapy in Non-Prostate Cancers: Where Do We Stand? 81
The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study 81
Multi-centre data harmonisation applied to heart-to-mediastinum quantification in parkinsonism (ITA-MIBG): a cross-calibration phantom study with tube and bottle 79
18F-FDG PET/CT (PET) and serum neurodegenerative biomarkers (NB) in suspected cognitive disorders (CD): a preliminary study 76
First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review 74
Evaluation of Bone Scan Index as a Prognostic Tool in Breast Cancer Patients with Bone Metastasis 72
Utility of shape and texture features from [18F]-FDG PET to predict cervical nodal status in patients with head & neck cancer 71
The prognostic role of [18F]FDG PET/CT for suspected recurrence or monitoring systemic treatment in triplenegative breast cancer: preliminary results of the TRINE-PET trial. 71
The role of routine 131I-SPECT/CT use in differentiated thyroid carcinoma (DTC) follow-up 71
The Role of Risk Factors for the Progression of Patients with T1b-T2 Papillary Thyroid Carcinoma (PC) during Long-Term Follow-Up 71
Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy 70
Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and Outcome during Long-Term Follow-Up 68
Usefulness of PET/CT with 18F-FDG in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy: An Italian Multicenter Study 64
Prognostic role of minimal extrathyroidal tumor extension (mETE) in the follow-up of patients with papillary carcinoma (PC) unaffected by other risk factors. 63
Radiomics Features from Positron Emission Tomography with [18F] Fluorodeoxyglucose Can Help Predict Cervical Nodal Status in Patients with Head and Neck Cancer 63
Qualitative and Semiquantitative Parameters of 18F-FDG-PET/CT as Predictors of Malignancy in Patients with Solitary Pulmonary Nodule 58
Role of Functional Neuroimaging with 123I-MIBG and 123I-FP-CIT in De Novo Parkinson's Disease: A Multicenter Study 57
Radionuclide-based nanotechnologies in brain tumors: an updated overview 51
Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer 51
The prognostic role of baseline and post neoadjuvant chemotherapy [18F]FDG PET/CT in triple-negative breast cancer: preliminary results of the TRINE-PET trial 49
Long-term follow-up of patients thyroidectomized for thyroid papillary carcinoma (PC) with associated Graves’s disease (GD): a 131I-SPECT/CT diagnostic study 47
The impact of [18F]FDG PET/CT in guiding the change of management of triple-negative breast cancer patients: a sub-analysis of the TRINE-PET trial 12
Diagnostic Accuracy of DaTQUANT® Versus BasGanV2™ for 123I-Ioflupane Brain SPECT: A Machine Learning-Based Differentiation of Parkinson’s Disease and Essential Tremor 11
Artificial Intelligence in PET Imaging for Alzheimer’s Disease: A Narrative Review 11
Totale 5.462
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.269
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 5 0 5 6 0 0
2021/202243 5 2 8 0 0 2 0 3 2 2 2 17
2022/2023153 8 14 2 35 8 30 4 15 26 2 6 3
2023/2024370 42 28 9 33 94 41 0 6 1 20 26 70
2024/20252.126 44 48 121 96 79 100 106 321 664 313 124 110
2025/20262.668 179 832 610 480 393 174 0 0 0 0 0 0
Totale 5.462